bpc 157 human clinical trial dosing bpc-157 protocol BPC-157 Dosing (Common Protocols) πΉ Oral / Subcutaneous β’ 500 mcg daily β’ Duration: 6 weeks πΉ Intramuscular / Peritendinous β’ 1 mg daily β’ Duration: 6 weeks β οΈ Note: Not approved Wolverine Stack: Healing Faster with
Description
Over a 10-dose vial cycle, dead space can waste 0.5 to 1.75mg
However, it's commonly discussed alongside injectable peptides because of its similar administration methods and its role in hormone optimization protocols
You'll need bacteriostatic water, the HCG vial containing lyophilized powder, alcohol swabs for sterilization, a sterile syringe for mixing, and appropriate needles
Oral or injectable forms
GHK-Cu, or glycyl-L-histidyl-L-lysine copper, is a naturally occurring tripeptide first found in human plasma
Peptides may be one part of that plan for some people
